Update on pediatric psoriasis, part 2: Therapeutic management

Cutis

Volumn 86, Issue 4, 2010, Pages 172-176

  Silverberg, Nanette B ^a,b,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; IMMUNOLOGIC FACTOR;

ARTICLE; CHILD; DIET SUPPLEMENTATION; HOSPITALIZATION; HUMAN; IMMUNOLOGY; METHODOLOGY; PATHOPHYSIOLOGY; PHOTOTHERAPY; PSORIASIS;

CHILD; DERMATOLOGIC AGENTS; DIETARY SUPPLEMENTS; HUMANS; IMMUNOLOGIC FACTORS; PHOTOTHERAPY; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 78650603920     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Silverberg NB. Update on pediatric psoriasis, part 1: clinical features and demographics. Cutis. 2010;86:118-124.
2. Silverberg NB. Pediatric psoriasis: an update. Ther Clin Risk Manag. 2009;5:849-856.
3. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155:145-151.
4. Paller AS, Siegfried EC, Langley RG, et al; Etanercept Pediatric Psoriasis Study Group. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358:241-251.
5. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial [published online ahead of print April 7, 2009]. Am J Gastroenterol. 2009;104:1170-1179.
6. Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr Dermatol. 2004;21:87-88.
7. Borska L, Andrys C, Krejsek J, et al. Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen. Pediatr Dermatol. 2009;26:23-27.
8. Farber EM, Nall L. Childhood psoriasis. Cutis. 1999;64: 309-314.
9. van de Kerkhof PC, van der Valk PG, Swinkels OQ, et al. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. Br J Dermatol. 2006;155:800-807.
10. Kimball AB, Gold MH, Zib B, et al. Clobetasol propionate emulsion formulation foam phase III clinical study group. clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008;59:448-454, 454e1.
11. Oranje AP, Marcoux D, Svensson A, et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol. 1997;36(2, pt 1):203-208.
12. Liao YH, Chiu HC, Tseng YS, et al. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Br J Dermatol. 2007;157:1005-1012.
13. Kiken DA, Silverberg NB. Atopic dermatitis in children, part 2: treatment options. Cutis. 2006;78:401-406.
14. Herz G, Blum G, Yawalkar S. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis. J Am Acad Dermatol. 1991;25(6, pt 2):1166-1169.
15. Brune A, Miller DW, Lin P, et al. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol. 2007;24:76-80.
16. Hebert AA, Warken KA, Cherill R. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases. Semin Cutan Med Surg. 2001;20:260-267.
17. Jain VK, Aggarwal K, Jain K, et al. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol. 2007;46:320-322.
18. Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol. 1996;13: 406-409.
19. Pasić A, Ceović R, Lipozencić J, et al. Phototherapy in pediatric patients. Pediatr Dermatol. 2003;20:71-77.
20. Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr Dermatol. 2003;20:506-510.
21. Wilson JK, Al-Suwaidan SN, Krowchuk D, et al. Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol. 2003;20:11-15.
22. Dogan B, Karabudak O, Harmanyeri Y. Antistreptococcal treatment of guttate psoriasis: a controlled study. Int J Dermatol. 2008;47:950-952.
23. Saxena VN, Dogra J. Long-term oral azithromycin in chronic plaque psoriasis: a controlled trial [published online ahead of print March 19, 2010]. Eur J Dermatol. 2010;20:329-333.
24. Collin B, Vani A, Ogboli M, et al. Methotrexate treatment in 13 children with severe plaque psoriasis [published online ahead of print October 30, 2008]. Clin Exp Dermatol. 2009;34:295-298.
25. Kaur I, Dogra S, De D, et al. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol. 2008;25:184-188.
26. Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Therapy Lett. 2008;13:1-3.
27. Gisondi P, Fantuzzi F, Malerba M, et al. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18:138-146.
28. Davis A, Krafchik BR. New drugs in pediatric dermatology. Curr Opin Pediatr. 1993;5:212-215.
29. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49:171-182.
30. Lovell DJ, Reiff A, Ilowite NT, et al; Pediatric Rheumatology Collaborative Study Group. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008;58:1496-1504.
31. Morbach H, Richl P, Stojanov S, et al. Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment [published online ahead of print April 19, 2009]. Rheumatol Int. doi:10.1007/s00296-009-0937-0.
32. Nielsen S, Ruperto N, Gerloni V, et al; Italian Pediatric Rheumatology Study Group. Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2008;26: 688-692.
33. Lovell DJ, Giannini EH, Reiff A, et al; Pediatric Rheumatology Collaborative Study Group. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003;48:218-226.
34. Hawrot AC, Metry DW, Theos AJ, et al. Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol. 2006;23:67-71.
35. Mayser P, Mrowietz U, Arenberger P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol. 1998;38:539-547.
36. Grattan C, Burton JL, Manku M, et al. Essential-fatty-acid metabolites in plasma phospholipids in patients with ichthyosis vulgaris, acne vulgaris and psoriasis. Clin Exp Dermatol. 1990;15:174-176.
37. Fahrer H, Hoeflin F, Lauterburg BH, et al. Diet and fatty acids: can fish substitute for fish oil? Clin Exp Rheumatol. 1991;9:403-406.
38. Lin YK, Yen HR, Wong WR, et al. Successful treatment of pediatric psoriasis with Indigo naturalis composite ointment. Pediatr Dermatol. 2006;23:507-510.